Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Compugen Ltd (NASDAQ:CGEN)

4.98
Delayed Data
As of Sep 02
 +0.08 / +1.63%
Today’s Change
4.64
Today|||52-Week Range
10.02
-40.22%
Year-to-Date
No recent news for Compugen Ltd.

Today’s Trading

Previous close4.90
Today’s open5.00
Day’s range4.89 - 5.05
Volume70,909
Average volume (3 months)155,127
Market cap$247.3M
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+36.11%
Earnings growth (this year)-50.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+248.46%
P/E ratioNM
Price/Sales32.59
Price/Book2.32

Competitors

 Today’s
change
Today’s
% change
BTXBioTime Inc+0.16+5.42%
CBMGCellular Biomedicine...+0.83+3.63%
ONVOOrganovo Holdings In...+0.19+7.76%
ENZYEnzymotec Ltd+0.53+5.33%
Data as of 09/02/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$12.4M
Annual profit (last year)-$11.1M
Net profit margin-89.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Anat Cohen-Dayag
Chief Financial Officer
Ari Krashin
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers